28.08.2016 Views

THREE EX-BARCLAYS BANKERS CONVICTED OVER LIBOR SCANDAL

cityam-2016-07-05-577af9476f73f

cityam-2016-07-05-577af9476f73f

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

CITYAM.COM<br />

TUESDAY 5 JULY 2016<br />

NEWS<br />

11<br />

Pharma industry<br />

in UK could gain<br />

from Brexit vote<br />

BILLY BAMBROUGH<br />

@BillyBambrough<br />

THE UK pharmaceuticals sector could<br />

benefit from the country’s vote to quit<br />

the European Union, according to new<br />

research.<br />

A loss of some funding and a socalled<br />

brain drain as employees relocate<br />

abroad in the short term is not<br />

expected to have a significant impact<br />

on long term growth, business intelligence<br />

firm BMI Research found.<br />

“While the bearish case for the UK’s<br />

pharmaceutical research and development<br />

(R&D) sector as a result of Brexit<br />

has been widely articulated, the<br />

upside risks are underappreciated,”<br />

the report authors wrote.<br />

BMI found the UK’s strong scientific<br />

base and existing R&D partnerships<br />

with companies and organisations<br />

across the EU will allow it to enter<br />

negotiations for the continued access<br />

to EU R&D funds. The report did warn<br />

over the risks associated with renegotiation<br />

of the UK’s trade deals.<br />

“Hammering out deals with the EU<br />

over the coming years will entail a<br />

great deal of time and uncertainty,<br />

and there is a risk that the UK will<br />

receive a punitive deal as it will be<br />

negotiating from a perceived position<br />

of weakness,” BMI analysts wrote.<br />

“However, amid the negative sentiment<br />

surrounding the UK’s prospects<br />

of going it alone, we highlight that the<br />

UK’s world class science base, its<br />

strong position within the global R&D<br />

arena and the country’s international<br />

research collaborations will work<br />

towards keeping British science at the<br />

forefront of research.”<br />

Pharma accounted for the highest<br />

level of business R&D expenditure for<br />

a product group in 2014, according to<br />

the Office for National Statistics. It<br />

represented 20 per cent of total expenditure<br />

and clocked up almost £4bn of<br />

spending. It was followed by<br />

computer programming and information<br />

services activities at £2.35bn.<br />

SUPER RESULTS High street chemist<br />

Superdrug sees profits rise 62 per cent<br />

SUPERDRUG is set to file accounts at companies house showing operating profit of<br />

£62.2m in 2015, up from £38.2m the year before. Sales from like-for-like stores<br />

increased by 6.6 per cent, with make-up and beauty growing 11 per cent.<br />

Small business<br />

confidence fell<br />

before Brexit<br />

HELEN CAHILL<br />

@HelCahill<br />

SMALL business confidence was at<br />

a four-year low before the EU<br />

referendum, according to data<br />

from the Federation of Small<br />

Businesses (FSB).<br />

A survey from the FSB,<br />

conducted before the Brexit vote,<br />

also found smaller companies are<br />

planning to cut jobs for a second<br />

quarter in a row. Members said<br />

their profits are falling due to the<br />

increased cost of labour and tax<br />

burdens.<br />

Only 12.2 per cent of businesses<br />

surveyed said they planned new<br />

capital investment over the next<br />

year - down from 31.9 per cent a<br />

year ago.<br />

Mike Cherry, FSB chairman, said<br />

the government should push<br />

forward on expanding small<br />

business rate relief and that the<br />

Low Pay Commission should be<br />

“especially vigilant” when making<br />

recommendations on minimum<br />

wage rates next year.<br />

“We need to do everything we<br />

can to support small firms to grow,<br />

create jobs, and weather the harsh<br />

economic headwinds,” he added.<br />

Clarkson’s share price sinks after it<br />

warns profits will be lower this year<br />

HELEN CAHILL<br />

@HelCahill<br />

SHIPBROKER Clarkson’s share price<br />

tanked 16.1 per cent to 1,850p<br />

yesterday after the group said its<br />

profits will be “materially lower” this<br />

year.<br />

The group said global economic<br />

uncertainty and an imbalance<br />

between supply and demand in<br />

shipping and offshore meant the<br />

industry “remains depressed”,<br />

despite the recovery of oil prices.<br />

The FTSE 250 group said: “While<br />

recent strengthening of the US<br />

dollar against sterling, if sustained,<br />

will offer some limited enhancement<br />

to reported profits, the board<br />

anticipates that as a consequence of<br />

the challenges... profits for 2016 will<br />

be materially lower.”<br />

CLARKSON<br />

2,300 P<br />

2,200<br />

2,100<br />

2,000<br />

1,900<br />

1,800<br />

1,700<br />

4 July<br />

1,850.00<br />

28 June 29 June 30 June 1 July<br />

4 July<br />

Fund manager to keep London<br />

as European base after Brexit<br />

WILLIAM TURVILL<br />

@wturvill<br />

COLUMBIA Threadneedle has committed<br />

to keeping its European headquarters<br />

in London after Brexit.<br />

The fund manager confirmed it has<br />

“begun the process of applying to<br />

expand the scope of our Luxembourgbased<br />

management company to<br />

enable us to establish an asset management<br />

presence in the EU”.<br />

But a spokesperson added: “We will<br />

not be moving our EMEA<br />

headquarters from London and the<br />

vast majority of our employees can<br />

expect to remain where they are currently<br />

located.”<br />

The commitment to London comes<br />

at a time when several asset managers<br />

are being linked with staff and fund<br />

movements away from the UK.<br />

The Investment Association is holding<br />

a meeting today to discuss the<br />

impact of Brexit with its asset<br />

manager members.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!